NEWS: August 2009 Archives - Ben Franklin Technology Partners of PennsylvaniaSubscribe
NuPathe Reports Positive Phase III Results For Zelrix, A Novel Transdermal Patch For Acute Migraine
NuPathe Inc., a BFTP supported specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, today announced top-line results from the pivotal Phase III clinical trial of Zelrix™, a nov... Read More